Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/24/15 → 3/24/18 |
Funding
- Duke Clinical Research Institute (GS-US-218-1502 // GS-US-218-1502)
- Gilead Sciences, Inc (GS-US-218-1502 // GS-US-218-1502)
GS-US-218-1502, “A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial V
- Ison, Michael G (PD/PI)
Project: Research project